1. The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial. Issue 10 (July 2015) Authors: Dirven, Linda; van den Bent, Martin J.; Bottomley, Andrew; van der Meer, Nelly; van der Holt, Bronno; Vos, Maaike J.; Walenkamp, Annemiek M.E.; Beerepoot, Laurens V.; Hanse, Monique C.J.; Reijneveld, Jaap C.; Otten, Aja; de Vos, Filip Y.F.L.; Smits, Marion; Bromberg, Jacoline E.C.; Taal, Walter; ... Journal: European journal of cancer Issue: Volume 51:Issue 10(2015:Jul.) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗